Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Injectable Scaffold for Bone Marrow Stem Cells and Bone Morphogenetic Protein-2 to Repair Cartilage.

Vayas R, Reyes R, Arnau MR, Évora C, Delgado A.

Cartilage. 2019 Apr 11:1947603519841682. doi: 10.1177/1947603519841682. [Epub ahead of print]

PMID:
30971092
2.

In situ gel-forming system for dual BMP-2 and 17β-estradiol controlled release for bone regeneration in osteoporotic rats.

Segredo-Morales E, Reyes R, Arnau MR, Delgado A, Évora C.

Drug Deliv Transl Res. 2018 Oct;8(5):1103-1113. doi: 10.1007/s13346-018-0574-9.

PMID:
30105738
3.

Amyloid cardiomyopathy: a hidden heart failure cause that is often misdiagnosed.

Tung-Chen Y, Arnau MÁ.

Acta Clin Belg. 2018 Dec;73(6):460-461. doi: 10.1080/17843286.2018.1461179. Epub 2018 Apr 17.

PMID:
29663861
4.

Combined sustained release of BMP2 and MMP10 accelerates bone formation and mineralization of calvaria critical size defect in mice.

Reyes R, Rodríguez JA, Orbe J, Arnau MR, Évora C, Delgado A.

Drug Deliv. 2018 Nov;25(1):750-756. doi: 10.1080/10717544.2018.1446473.

5.

Iohexol plasma clearance, a simple and reliable method to measure renal function in conscious mice.

Luis-Lima S, Rodríguez-Rodríguez AE, Martín-Higueras C, Sierra-Ramos C, Carrara F, Arnau MR, Alvarez de la Rosa D, Salido E, Gaspari F, Porrini E.

Pflugers Arch. 2016 Sep;468(9):1587-94. doi: 10.1007/s00424-016-1843-4. Epub 2016 Jun 17.

PMID:
27315812
6.

Deregulated hepatic microRNAs underlie the association between non-alcoholic fatty liver disease and coronary artery disease.

Braza-Boïls A, Marí-Alexandre J, Molina P, Arnau MA, Barceló-Molina M, Domingo D, Girbes J, Giner J, Martínez-Dolz L, Zorio E.

Liver Int. 2016 Aug;36(8):1221-9. doi: 10.1111/liv.13097. Epub 2016 Mar 23.

PMID:
26901384
7.

Sensitivity and negative predictive value of treadmill exercise stress testing for the diagnosis of catecholaminergic polymorphic ventricular tachycardia. Response.

Domingo D, López-Vilella R, Arnau MÁ, Zorio E.

Rev Esp Cardiol (Engl Ed). 2015 Jun;68(6):546-7. doi: 10.1016/j.rec.2015.02.011. Epub 2015 May 1. No abstract available.

PMID:
25936659
8.

Bacterial profile of aggressive periodontitis in Morocco: a cross-sectional study.

Chahboun H, Arnau MM, Herrera D, Sanz M, Ennibi OK.

BMC Oral Health. 2015 Feb 24;15:25. doi: 10.1186/s12903-015-0006-x.

9.

A new mutation in the ryanodine receptor 2 gene (RYR2 C2277R) as a cause catecholaminergic polymorphic ventricular tachycardia.

Domingo D, López-Vilella R, Arnau MÁ, Cano Ó, Fernández-Pons E, Zorio E.

Rev Esp Cardiol (Engl Ed). 2015 Jan;68(1):71-3. doi: 10.1016/j.rec.2014.07.022. Epub 2014 Nov 27. No abstract available.

PMID:
25435091
10.

Value of the Electrocardiogram as a Predictor of Right Ventricular Dysfunction in Patients With Chronic Right Ventricular Volume Overload.

Alonso P, Andrés A, Rueda J, Buendía F, Igual B, Rodríguez M, Osa A, Arnau MA, Salvador A.

Rev Esp Cardiol (Engl Ed). 2015 May;68(5):390-7. doi: 10.1016/j.rec.2014.04.019. Epub 2014 Oct 7.

PMID:
25304084
11.

Mice lacking chromogranins exhibit increased aggressive and depression-like behaviour.

Pereda D, Pardo MR, Morales Y, Dominguez N, Arnau MR, Borges R.

Behav Brain Res. 2015 Feb 1;278:98-106. doi: 10.1016/j.bbr.2014.09.022. Epub 2014 Sep 22.

PMID:
25257107
12.

Ex vivo and in vivo models for endoscopic submucosal dissection training.

Parra-Blanco A, Gonzalez N, Arnau MR.

Clin Endosc. 2012 Nov;45(4):350-7. doi: 10.5946/ce.2012.45.4.350. Epub 2012 Nov 30.

13.

[Peripheral arterial thromboembolism in Crohn's disease].

Ferrer I, Benavent G, Bastida G, Arnau MÁ, Iborra M, Beltrán B, Aguas M, Hinojosa J, Nos P.

Gastroenterol Hepatol. 2013 Jan;36(1):30-4. doi: 10.1016/j.gastrohep.2012.04.011. Epub 2012 Jun 29. Spanish.

PMID:
22749513
14.

Flecainide, a therapeutic option in a patient with long QT syndrome type 3 caused by the heterozygous V411M mutation in the SCN5A gene.

Carrasco JI, Izquierdo I, Medina P, Arnau MÁ, Salvador A, Zorio E.

Rev Esp Cardiol (Engl Ed). 2012 Nov;65(11):1058-9. doi: 10.1016/j.recesp.2012.03.014. Epub 2012 Jun 19. English, Spanish. No abstract available.

PMID:
22721569
15.

Gastric endoscopic submucosal dissection assisted by a new traction method: the clip-band technique. A feasibility study in a porcine model (with video).

Parra-Blanco A, Nicolas D, Arnau MR, Gimeno-Garcia AZ, Rodrigo L, Quintero E.

Gastrointest Endosc. 2011 Nov;74(5):1137-41. doi: 10.1016/j.gie.2011.07.037.

PMID:
22032320
16.

[Differential features of female alcoholism].

Arnau MM.

Adicciones. 2010;22(4):339-52. Review. Spanish.

17.

Endoscopic submucosal dissection training with pig models in a Western country.

Parra-Blanco A, Arnau MR, Nicolás-Pérez D, Gimeno-García AZ, González N, Díaz-Acosta JA, Jiménez A, Quintero E.

World J Gastroenterol. 2010 Jun 21;16(23):2895-900.

18.

Nuclear magnetic resonance imaging in patients with cardiac pacing devices.

Buendía F, Sánchez-Gómez JM, Sancho-Tello MJ, Olagüe J, Osca J, Cano O, Arnau MA, Igual B.

Rev Esp Cardiol. 2010 Jun;63(6):735-9.

19.

The mineralocorticoid receptor is a constitutive nuclear factor in cardiomyocytes due to hyperactive nuclear localization signals.

Hernández-Díaz I, Giraldez T, Arnau MR, Smits VA, Jaisser F, Farman N, Alvarez de la Rosa D.

Endocrinology. 2010 Aug;151(8):3888-99. doi: 10.1210/en.2010-0099. Epub 2010 May 19.

PMID:
20484457
20.

Chromogranins as regulators of exocytosis.

Borges R, Díaz-Vera J, Domínguez N, Arnau MR, Machado JD.

J Neurochem. 2010 Jul;114(2):335-43. doi: 10.1111/j.1471-4159.2010.06786.x. Epub 2010 Apr 29. Review.

21.

Impact on allergic immune response after treatment with vitamin A.

Matheu V, Berggård K, Barrios Y, Barrios Y, Arnau MR, Zubeldia JM, Baeza ML, Back O, Issazadeh-Navikas S.

Nutr Metab (Lond). 2009 Oct 23;6:44. doi: 10.1186/1743-7075-6-44.

22.

Training model for teaching endoscopic submucosal dissection of gastric tumors.

Vázquez-Sequeiros E, de Miquel DB, Olcina JR, Martín JA, García M, Lucas DJ, Garrido E, González C, Blanco AP, Arnau MR, Buenadicha A, Vicente VM, de Argila CM, Milicua JM.

Rev Esp Enferm Dig. 2009 Aug;101(8):546-52.

23.

Similar response in male and female B10.RIII mice in a murine model of allergic airway inflammation.

Matheu V, Barrios Y, Arnau MR, Navikas V, Issazadeh-Navikas S.

Inflamm Res. 2010 Apr;59(4):263-9. doi: 10.1007/s00011-009-0094-7. Epub 2009 Sep 25.

PMID:
19779803
24.

Insights into the role of microRNAs in cardiac diseases: from biological signalling to therapeutic targets.

Zorio E, Medina P, Rueda J, Millán JM, Arnau MA, Beneyto M, Marín F, Gimeno JR, Osca J, Salvador A, España F, Estellés A.

Cardiovasc Hematol Agents Med Chem. 2009 Jan;7(1):82-90. Review.

PMID:
19149547
25.

Using the temperament and character inventory (TCI) to predict outcome after inpatient detoxification during 100 days of outpatient treatment.

Arnau MM, Mondon S, Santacreu JJ.

Alcohol Alcohol. 2008 Sep-Oct;43(5):583-8. doi: 10.1093/alcalc/agn047. Epub 2008 Jun 10.

PMID:
18544710
26.

Treatment in a haemophiliac A patient with paroxysmal atrial fibrillation and ischemic heart disease.

Cid AR, Zorio E, Haya S, Zúñiga P, Rueda J, Casaña P, Cabrera N, Arnau MA, Aznar JA.

Haemophilia. 2007 Nov;13(6):760-2. No abstract available.

PMID:
17973853
27.

Interspecific recombinant congenic strains between C57BL/6 and mice of the Mus spretus species: a powerful tool to dissect genetic control of complex traits.

Burgio G, Szatanik M, Guénet JL, Arnau MR, Panthier JJ, Montagutelli X.

Genetics. 2007 Dec;177(4):2321-33. Epub 2007 Oct 18.

28.

Prognostic value of brain natriuretic peptide in heart transplant patients.

Martinez-Dolz L, Almenar L, Moro J, Agüero J, Hervas I, Rueda J, Rivera M, Arnau MA, Mateo A, Salvador A.

J Heart Lung Transplant. 2007 Oct;26(10):986-91.

PMID:
17919617
29.

mTOR inhibitors and their secondary effects in cardiac transplant recipients: a descriptive study.

Moro J, Almenar L, Martínez-Dolz L, Izquierdo M, Rueda J, Arnau MA, Agüero J, Sánchez-Lázaro I, Ortiz V, Salvador A.

Transplant Proc. 2007 Sep;39(7):2365-7.

PMID:
17889191
30.

mTOR inhibitors: do they help preserve renal function?

Moro J, Almenar L, Martínez-Dolz L, Agüero J, Rueda J, Arnau MA, Izquierdo M, Cano O, Sánchez-Lázaro I, Salvador A.

Transplant Proc. 2007 Sep;39(7):2135-7.

PMID:
17889116
31.

[Impact of diabetes mellitus on heart transplant recipients].

Moro JA, Martínez-Dolz L, Almenar L, Martínez-Ortiz L, Chamorro C, García C, Arnau MA, Rueda J, Zorio E, Salvador A.

Rev Esp Cardiol. 2006 Oct;59(10):1033-7. Spanish.

32.

Variations in the frequency and type of infections in heart transplantation according to the immunosuppression regimen.

Agüero J, Almenar L, Martinez-Dolz L, Chamorro C, Moro J, Zorio E, Arnau MA, Rueda J, Izquierdo M, Salvador A.

Transplant Proc. 2006 Oct;38(8):2558-9.

PMID:
17098001
33.

Evolutional changes in maintenance immunosuppression following heart transplantation.

Sánchez-Lázaro I, Almenar L, Martínez-Dolz L, Chamorro C, Moro J, Agüero J, Rueda J, Zorio E, Arnau MA, Salvador A.

Transplant Proc. 2006 Oct;38(8):2553-4.

PMID:
17097999
34.

Influence of immunosuppression regimen on heart transplantation survival.

Agüero J, Almenar L, Martínez-Dolz L, Chamorro C, Moro J, Rueda J, Arnau MA, Zorio E, Izquierdo M, Salvador A.

Transplant Proc. 2006 Oct;38(8):2550-2.

PMID:
17097998
35.

Induction therapy with daclizumab in heart transplantation--how many doses?

Ortiz V, Almenar L, Martínez-Dolz L, Zorio E, Chamorro C, Moro J, Agüero J, Rueda J, Arnau MA, Salvador A.

Transplant Proc. 2006 Oct;38(8):2541-3.

PMID:
17097995
36.

Does amiodarone influence early mortality in heart transplantation?

Sánchez-Lázaro IJ, Almenar L, Martinez-Dolz L, Chamorro C, Moro J, Agüero J, Rueda J, Zorio E, Arnau MA, Salvador A.

Transplant Proc. 2006 Oct;38(8):2537-8.

PMID:
17097993
37.

Is there a correlation between brain naturietic peptide levels and echocardiographic and hemodynamic parameters in heart transplant patients?

Almenar L, Arnau MA, Martínez-Dolz L, Hervás I, Osa A, Miró V, Sánchez E, Zorio E, Rueda J, Mateo A, Salvador A.

Transplant Proc. 2006 Oct;38(8):2534-6.

PMID:
17097992
38.

[Takotsubo syndrome with coronary lesions].

Moro JA, Arnau MA, Sánchez E, Almenar L.

Rev Esp Cardiol. 2006 Jun;59(6):632-3. Spanish. No abstract available.

39.

Lipoprotein (a) in young individuals as a marker of the presence of ischemic heart disease and the severity of coronary lesions.

Zorio E, Falco C, Arnau MA, España F, Osa A, Ramon LA, Castello R, Almenar L, Palencia MA, Estelles A.

Haematologica. 2006 Apr;91(4):562-5.

40.

Predictive factors for development of diabetes mellitus post-heart transplant.

Martínez-Dolz L, Almenar L, Martínez-Ortiz L, Arnau MA, Chamorro C, Moro J, Osa A, Rueda J, García C, Palencia M.

Transplant Proc. 2005 Nov;37(9):4064-6.

PMID:
16386627
41.

Influence of induction therapy on rejection and survival in heart transplantation.

Almenar L, García-Palomar C, Martínez-Dolz L, Chamorro C, Moro J, Zorio E, Arnau MA, Rueda J, Osa A, Cardo ML.

Transplant Proc. 2005 Nov;37(9):4024-7.

PMID:
16386616
42.

Risk factors affecting survival in heart transplant patients.

Almenar L, Cardo ML, Martínez-Dolz L, García-Palomar C, Rueda J, Zorio E, Arnau MA, Osa A, Palencia M.

Transplant Proc. 2005 Nov;37(9):4011-3.

PMID:
16386612
43.

The presence of epsilon waves in a patient with acute right ventricular infarction.

Zorio E, Arnau MA, Rueda J, Almenar L, Osa A, Martínez-Dolz L, Osca J, Palencia MA.

Pacing Clin Electrophysiol. 2005 Mar;28(3):245-7.

PMID:
15733188
44.

Ventricular natriuretic peptide (BNP) in heart transplantation: BNP correlation with endomyocardial biopsy, laboratory and hemodynamic measures.

Hervás I, Arnau MA, Almenar L, Pérez-Pastor JL, Chirivella M, Osca J, Bello P, Osa A, Martí JF, Vera F, Mateo A.

Lab Invest. 2004 Jan;84(1):138-45.

45.

Utility of cardiac magnetic resonance imaging for the diagnosis of heart transplant rejection.

Almenar L, Igual B, Martínez-Dolz L, Arnau MA, Osa A, Rueda J, Palencia M.

Transplant Proc. 2003 Aug;35(5):1962-4.

PMID:
12962864
46.

Radioimmunometric assay of B-type natriuretic peptide (BNP) in heart transplantation: correlation between BNP determinations and biopsy grading of rejection.

Hervás I, Almenar L, Pérez-Pastor JL, Chirivella M, Osa A, Martínez-Dolz L, Bello P, Martí JF, Arnau MA, Vera F, Rueda J, Palencia M, Mateo A.

Nucl Med Commun. 2003 Aug;24(8):925-31.

PMID:
12869826
47.

[Analysis of factors that can influence the appearance of acute heart transplant failure].

Martínez-Dolz L, Almenar L, Arnau MA, Osa A, Rueda J, Vicente JL, García-Sánchez F, Palencia M, Caffarena JM.

Rev Esp Cardiol. 2003 Feb;56(2):168-74. Spanish.

48.

Radioimmunometric assay of natriuretic peptide type-B (BNP) in heart failure.

Hervas I, Osca J, Perez-Pastor JL, Quesada A, Arnau MA, Marti JF, Almenar L, Bello P, Mateo A.

Nucl Med Commun. 2003 Jan;24(1):61-9.

PMID:
12501021
49.

[Usefulness of the electrocardiogram in predicting the occlusion site in acute anterior myocardial infarction with isolated disease of the left anterior descending coronary artery].

Martínez-Dolz L, Arnau MA, Almenar L, Rueda J, Osa A, Quesada A, Osca J, Zorio E, Palencia M, Cebolla R.

Rev Esp Cardiol. 2002 Oct;55(10):1036-41. Spanish.

50.

A new locus for resistance to gamma-radiation-induced thymic lymphoma identified using inter-specific consomic and inter-specific recombinant congenic strains of mice.

Santos J, Montagutelli X, Acevedo A, López P, Vaquero C, Fernández M, Arnau MR, Szatanik M, Salido E, Guénet JL, Fernández-Piqueras J.

Oncogene. 2002 Sep 26;21(43):6680-3.

Supplemental Content

Support Center